Lupin

We are well-aligned to capitalise on the CDMO opportunity

Read more

Lupin gains USFDA nod for Raltegravir Tablets USP, 600 mg

Read more

Lupin receives US FDA approval for generic Tolvaptan Tablets

Read more

US FDA issues EIR for Lupin’s injectable facility in Nagpur

Read more

Leadership Lens

Read more

Lupin gains tentative USFDA approval for Amifampridine Tablets

Read more

Lupin included in S&P Global Sustainability Yearbook 2025 for the second consecutive year

Read more

Lupin receives US FDA Establishment Inspection Report for Somerset facility

Read more

Lupin receives “A-” leadership rating from CDP for climate change and water security

Read more

Lupin receives U.S. FDA approval for generic Ipratropium Bromide nasal spray

Read more